To study and compare two drug combinations used in cataract surgery to reduce pain and sensation during surgery.

COMPARISON OF 0.5% ROPIVACAINE- 2% LIDOCAINE COMBINATION VERSUS 0.5% BUPIVACAINE-2% LIDOCAINE COMBINATION FOR PERIBULBAR BLOCK ANAESTHESIA IN MANUAL SMALL INCISION CATARACT SURGERY- AN OBSERVATIONAL STUDY - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2024/06/069104

Enrollment

Registered

2024-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H251- Age-related nuclear cataract

Interventions

Intervention1: Ropivacaine: Dose: 2ml of 0.5% Ropivacaine and 3ml of 2% lidocaine combination (total 5ml) Frequency: single dose Route of administration: peribulbar injection into the extraconal spac

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients undergoing surgery above 18 years of age and without other co-morbidities.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patients with allergy to local anesthetics Post traumatic cataract Myopic with axial length more than 26mm Patients on anticoagulant therapy or with bleeding diathesis

Design outcomes

Primary

Measure	Time frame
Onset and duration of anesthesia.Timepoint: 24 Hours	—

Secondary

Measure	Time frame
To determine surgeon and patient satisfaction and amount of total analgesics required following surgery in the first 24 hours with 0.5%Ropivacaine-2%Lidocaine combination and 0.5%Bupivacaine-2%Lidocaine combination in peribulbar block anesthesia in manual small incision cataract surgery. Timepoint: Intraoperative assessment. For analgesics- within 24 hours after surgery	—

Countries

India

Contacts

Public ContactDr Sanjeev Kumar Yumnam

Department of ophthalmology, Mahatma Gandhi Medical College and Research Institute

srikanthk@mgmcri.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026